Porton Advanced provides end-to-end CDMO solutions for Advanced Therapy Medicinal Products (ATMPs), from cell banking, process and analyticals method development, GMP production to fill&finish, covering different stages of drug development from early research, investigator-initiated trials, Investigational new drug (IND) application, clinical trials, New drug application (NDA) to commercialization.
To accelerate the development and manufacture of advanced medicines to deliver life-changing benefits to patients.
To be a leading global ATMP CRO and CDMO, supporting our partners in delivering quality advanced medicines through innovation, care, and commitment.
Contact Porton to find the pharmaceutical small molecule R&D projects that best fits your business.
Building 3, Ascendas Park, No.388 Xinping Street, Suzhou Industrial Park, Jiangsu 215021, China
Get DirectionsMain Office, 6 Cedarbrook Dr., Cranbury, NJ 08512, USA
Phone: (908) 565-4183
Building 7, Phase III a of BioBAY, 1 Xinze Rd, Suzhou Industrial Park, Jiangsu 215021, China
Get DirectionsA committed team with global experience and expertise. Our experienced management team brings decades of industry experience and a track record of success in drug discovery, development and commercialization.
Porton Pharma Solutions, a global company with R&D, and GMP-compliant manufacturing facilities across US, EU and, provides customer-centric innovative, and reliable CDMO solutions for Small Molecules, Tides, Biologics and Conjugates (ADCs, AOCs, PDCs, etc.) from pre-clinical to commercial.